Randall E. Brand MD
Gastrointestinal Cancer
Professor, Medicine, University of Pittsburgh School of Medicine
Join to view full profile
5200 Centre AvenueSuite 409Pittsburgh, PA 15232
Phone+1 412-623-3105
Fax+1 412-623-3106
Dr. Brand is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Gastroenterology, 1991 - 1993
University of MichiganResidency, Internal Medicine, 1987 - 1990
University of Michigan Medical SchoolClass of 1987
Certifications & Licensure
CA State Medical License 1991 - Present
PA State Medical License 2007 - 2026
IL State Medical License 2002 - 2008
MI State Medical License 1989 - 1996
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2013
- CMS Meaningful Use Stage 1 Certification dbMotion, dbMotion Inc., 2012-2013
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsPancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium.Christine Worthington, Maria Raitses-Gurevich, Giulio Innamorati, Phil A Hart, Thomas M Wilkie
International Journal of Cancer. 2026-10-15 - INCREASED PREVALENCE OF PANCREATIC CYSTS IN NONSECRETOR (FUT2 NULL) INDIVIDUALS UNDER PANCREATIC SURVEILLANCE.Yuto Hozaka, Masataka Hayashi, Emy Abou Sleiman, Bryson W Katona, Randall E Brand
Cancer Epidemiology, Biomarkers & Prevention. 2026-10-08 - The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma from High-Risk Controls: A Retrospective Secondary...Tamas Gonda, Salvatore Paiella, Rosalie C Sears, Erkut Borazanci, Patricio M Polanco
Journal of Clinical Medicine. 2026-09-22
Journal Articles
- DNA Mismatch Repair Protein Deficient Non-Neoplastic Colonic Crypts: A Novel Indicator of Lynch SyndromeRish K Pai, Randall E Brand, Noralane M Lindor, Nature
- Recurrent Acute Pancreatitis Significantly Reduces Quality of Life Even in the Absence of Overt Chronic PancreatitisDhiraj Yadav, Bimaljit S Sandhu, Nalini M Guda, Vikesh K Singh, John Baillie, Randall Brand, Andres Gelrud, David C Whitcomb, Darwin Conwell, Stuart Sherman, Adam Sliv..., Nature
Press Mentions
Identifying Pancreatic Cancer Remains Elusive. Here’s WhyFebruary 18th, 2025- Immunovia Has Successfully Acquired All Blood Samples Required to Clinically Validate Its Next-Generation Test for Pancreatic CancerOctober 7th, 2024
- Genomic Analysis Shown to Detect Early Pancreatic CancerSeptember 29th, 2021
Grant Support
- Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesionsJOHNS HOPKINS UNIVERSITY2023–2028
- Validation of biomarkers for risk prediction and early diagnosis of Pancreatic AdenocarcinomaUNIVERSITY OF PITTSBURGH AT PITTSBURGH2016–2028
- PancreasFest 2025: Pancreas Disease Across the LifespanUNIVERSITY OF PITTSBURGH AT PITTSBURGH2025–2026
- Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancerUNIVERSITY OF PITTSBURGH AT PITTSBURGH2021–2026
- Subpopulations of Pancreatic Cancer Cells Defined by Glycan MarkersVAN ANDEL RESEARCH INSTITUTE2019–2025
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: